Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,518 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Successful treatment of infants with localized neuroblastoma based on their MYCN status.
Iehara T, Hamazaki M, Tajiri T, Kawano Y, Kaneko M, Ikeda H, Hosoi H, Sugimoto T, Sawada T; Japanese Infantile Neuroblastoma Cooperative Study Group. Iehara T, et al. Among authors: ikeda h. Int J Clin Oncol. 2013 Jun;18(3):389-95. doi: 10.1007/s10147-012-0391-y. Epub 2012 Mar 2. Int J Clin Oncol. 2013. PMID: 22383024
Neonatal neuroblastoma: incidence and clinical outcome.
Tsuchida Y, Ikeda H, Iehara T, Toyoda Y, Kawa K, Fukuzawa M. Tsuchida Y, et al. Among authors: ikeda h. Med Pediatr Oncol. 2003 Jun;40(6):391-3. doi: 10.1002/mpo.10235. Med Pediatr Oncol. 2003. PMID: 12692810 No abstract available.
Current treatment and future directions in neuroblastoma.
Tsuchida Y, Shitara T, Kuroiwa M, Ikeda H. Tsuchida Y, et al. Among authors: ikeda h. Indian J Pediatr. 2003 Oct;70(10):809-12. doi: 10.1007/BF02723804. Indian J Pediatr. 2003. PMID: 14649477 Clinical Trial.
Results of a phase II trial for high-risk neuroblastoma treatment protocol JN-H-07: a report from the Japan Childhood Cancer Group Neuroblastoma Committee (JNBSG).
Hishiki T, Matsumoto K, Ohira M, Kamijo T, Shichino H, Kuroda T, Yoneda A, Soejima T, Nakazawa A, Takimoto T, Yokota I, Teramukai S, Takahashi H, Fukushima T, Kaneko T, Hara J, Kaneko M, Ikeda H, Tajiri T, Nakagawara A; Japan Childhood Cancer Group Neuroblastoma Committee (JNBSG). Hishiki T, et al. Among authors: ikeda h. Int J Clin Oncol. 2018 Oct;23(5):965-973. doi: 10.1007/s10147-018-1281-8. Epub 2018 Apr 26. Int J Clin Oncol. 2018. PMID: 29700636 Clinical Trial.
Results of a prospective clinical trial JN-L-10 using image-defined risk factors to inform surgical decisions for children with low-risk neuroblastoma disease: A report from the Japan Children's Cancer Group Neuroblastoma Committee.
Iehara T, Yoneda A, Yokota I, Takahashi H, Teramukai S, Kamijyo T, Nakazawa A, Takimoto T, Kikuta A, Yagyu S, Ikeda H, Nakagawara A, Tajiri T; Japan Childhood Cancer Group Neuroblastoma Committee (JNBSG). Iehara T, et al. Among authors: ikeda h. Pediatr Blood Cancer. 2019 Nov;66(11):e27914. doi: 10.1002/pbc.27914. Epub 2019 Jul 24. Pediatr Blood Cancer. 2019. PMID: 31342649
Correction to: Results of a phase II trial for high-risk neuroblastoma treatment protocol JN-H-07: a report from the Japan Childhood Cancer Group Neuroblastoma Committee (JNBSG).
Hishiki T, Matsumoto K, Ohira M, Kamijo T, Shichino H, Kuroda T, Yoneda A, Soejima T, Nakazawa A, Takimoto T, Yokota I, Teramukai S, Takahashi H, Fukushima T, Kaneko T, Hara J, Kaneko M, Ikeda H, Tajiri T, Nakagawara A; Japan Childhood Cancer Group Neuroblastoma Committee (JNBSG). Hishiki T, et al. Among authors: ikeda h. Int J Clin Oncol. 2020 Sep;25(9):1744-1745. doi: 10.1007/s10147-020-01752-4. Int J Clin Oncol. 2020. PMID: 32749556
A nationwide phase II study of delayed local treatment for children with high-risk neuroblastoma: The Japan Children's Cancer Group Neuroblastoma Committee Trial JN-H-11.
Yoneda A, Shichino H, Hishiki T, Matsumoto K, Ohira M, Kamijo T, Kuroda T, Soejima T, Nakazawa A, Takimoto T, Yokota I, Teramukai S, Takahashi H, Fukushima T, Hara J, Kaneko M, Ikeda H, Tajiri T, Mugishima H, Nakagawara A. Yoneda A, et al. Among authors: ikeda h. Pediatr Blood Cancer. 2024 Jun;71(6):e30976. doi: 10.1002/pbc.30976. Epub 2024 Apr 5. Pediatr Blood Cancer. 2024. PMID: 38577760 Clinical Trial.
Results of the JRS-I LRA0401 and LRB0402 Japan Rhabdomyosarcoma Study Group trials for low-risk embryonal rhabdomyosarcoma.
Hosoi H, Miyachi M, Teramukai S, Sakabayashi S, Tsuchiya K, Kuwahara Y, Onodera R, Matsuyama K, Yokota I, Hojo H, Okita H, Hata JI, Hamasaki M, Tsuneyoshi M, Oda Y, Nakazawa A, Kato M, Takimoto T, Horibe K, Hara JI, Suita S, Hanada R, Masaki H, Nozaki M, Ikeda H, Kishimoto S, Kaneko M, Kawai A, Morikawa Y. Hosoi H, et al. Among authors: ikeda h. Int J Clin Oncol. 2024 Nov;29(11):1746-1755. doi: 10.1007/s10147-024-02608-x. Epub 2024 Aug 23. Int J Clin Oncol. 2024. PMID: 39177879
4,518 results